Retatrutide

Retatrutide is a novel triple agonist peptide that simultaneously targets GLP-1, GIP, and glucagon receptors. This unique mechanism of action has made it a subject of significant research interest in the field of metabolic health and weight management. Studies have explored its potential to support metabolic processes through multiple signaling pathways, distinguishing it from single or dual agonist compounds.